ConductScience.org, home

Paper41219086

Post-translational modifications of NLRP3: to prime or not to prime?

Dufies O and 1 other. Trends Immunol, 2026. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Post-translational modifications of NLRP3: to prime or not to prime? Papers, record 41219086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41219086

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Post-translational modifications of NLRP3: to prime or not to prime?
PubMed
Journal
Trends Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
2.86, provisional
iCite
Revised in PubMed
2026-08-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dufies OOcéane
2Zanoni IIvan

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein Processing, Post-TranslationalMajor topic
NLR Family, Pyrin Domain-Containing 3 ProteinMajor topic
InflammasomesMajor topic
Humans
Animals
Signal Transduction
Inflammation

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI170632NIAID NIH HHSUnited StatesR01AI170632PubMed

Source NIH RePORTER

Download CSV of grants

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136127465How location and cellular signaling combine to activate the NLRP3 inflammasome.Cell Mol Immunol2022https://conductscience.org/library/papers/36127465PubMed
227548431NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations.Nat Immunol2016https://conductscience.org/library/papers/27548431PubMed
326611636Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion.Cell Res2015https://conductscience.org/library/papers/26611636PubMed
415030775NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.Immunity2004https://conductscience.org/library/papers/15030775PubMed
537198476Structural basis of NINJ1-mediated plasma membrane rupture in cell death.Nature2023https://conductscience.org/library/papers/37198476PubMed
631895698Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis.J Clin Invest2020https://conductscience.org/library/papers/31895698PubMed
737781816BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis.Circulation2023https://conductscience.org/library/papers/37781816PubMed
834554188BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.J Exp Med2021https://conductscience.org/library/papers/34554188PubMed
920835230Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.Nat Immunol2010https://conductscience.org/library/papers/20835230PubMed
1030046112New mitochondrial DNA synthesis enables NLRP3 inflammasome activation.Nature2018https://conductscience.org/library/papers/30046112PubMed
1116301671Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis.J Immunol2005https://conductscience.org/library/papers/16301671PubMed
1229599418New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID).J Med Genet2018https://conductscience.org/library/papers/29599418PubMed
1333691097Itaconate confers tolerance to late NLRP3 inflammasome activation.Cell Rep2021https://conductscience.org/library/papers/33691097PubMed
1436178239TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.EMBO Rep2022https://conductscience.org/library/papers/36178239PubMed
1521484785Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.Eur J Immunol2011https://conductscience.org/library/papers/21484785PubMed
1638266638Serine synthesis sustains macrophage IL-1β production via NAD+-dependent protein acetylation.Mol Cell2024https://conductscience.org/library/papers/38266638PubMed
1734518217TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34518217PubMed
1839187689Gasdermins as evolutionarily conserved executors of inflammation and cell death.Nat Cell Biol2024https://conductscience.org/library/papers/39187689PubMed
1937651190Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation.J Clin Invest2023https://conductscience.org/library/papers/37651190PubMed
2039116210FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation.Cell Rep2024https://conductscience.org/library/papers/39116210PubMed

See all 101 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42923166The NLRP3 inflammasome as a bridge between myocardial infarction and depression: mechanisms, bidirectional link, and therapeutic potential.Front Cardiovasc Med2026https://conductscience.org/library/papers/42923166PubMed
42889843Metal-Organic Framework-Based Nanomedicine for Sepsis Therapy: From Microenvironment Regulation to Precision Therapeutic Strategies.Int J Nanomedicine2026https://conductscience.org/library/papers/42889843PubMed
42732341Tissue-Resident Macrophage in Inflammation and Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42732341PubMed
42650883The Role of Skeletal Muscle Mitochondria in NLRP3 Inflammasome Signaling.Biomolecules2026https://conductscience.org/library/papers/42650883PubMed
42464297The NLRP3 inflammasome in gastrointestinal malignancies: molecular mechanisms, regulatory networks, and therapeutic opportunities.J Transl Med2026https://conductscience.org/library/papers/42464297PubMed
42278349Mitochondrial Regulation of the NLRP3 Inflammasome in Diabetic Kidney Disease: From Mechanisms to Therapeutic Strategies.Int J Mol Sci2026https://conductscience.org/library/papers/42278349PubMed
41879501Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis.Bioessays2026https://conductscience.org/library/papers/41879501PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CASP1834PubTator's text mininghttps://conductscience.org/library/genes/834NCBI Gene
NLRP3114548PubTator's text mininghttps://conductscience.org/library/genes/114548NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41219086

GET https://conductscience.org/api/papers/v1/41219086/references?page=2